Tag: DO

Sessions

OBSERVATIONAL STUDIES ARE IN THE EYE OF THE BEHOLDER

There is a critical gap in evidence regarding whether different treatment strategies early in relapsing multiple sclerosis prevent...

Read More

Sessions

MRI INTERNATIONAL GUIDELINES

MRI is an invaluable tool for establishing an early diagnosis of MS and for monitoring patients’ disease course and response to treatment....

Read More

Sessions

EFFECTIVE ASSESSMENT AND MANAGEMENT STRATEGIES FOR COMPLEX SYMPTOMS OF MS

Multiple sclerosis is a chronic inflammatory and neurodegenerative disease of the CNS that commonly affects young adults. While advances in...

Read More

Poster-Symptom Management

Symptom Burden and Treatment Goals of People with MS Spasticity: Results from SEEN-MSS, a Large-Scale, Self-Reported Survey

Background: Evidence suggests that people with multiple sclerosis and spasticity (pwMSS) experience multiple concurrent symptoms that...

Read More

Poster-Quality of Life and Outcomes

The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care

Background: Johns Hopkins Specialty Pharmacy provides clinical services for eligible multiple sclerosis (MS) patients on oral and...

Read More

Poster-Programs

The Influence of Tethered and Joint HCP and Patient Education on Clinical Practice Behavior, Patient Activation, and Empowerment

Background: Advances in disease-modifying therapies (DMT) for multiple sclerosis (MS) have left clinicians challenged to incorporate DMTs,...

Read More

Poster-Multidisciplinary Care

National African American Multiple Sclerosis Registry: Advancing Equitable Care and Outcomes for African Americans with Multiple Sclerosis

Background: Historically, multiple sclerosis (MS) has been underdiagnosed among African Americans with MS (AAwMS). Recent evidence suggests...

Read More

Poster-Disease-modifying Therapy

Characteristics and Outcomes By Employment and Education Status for Patients Treated with Peginterferon Beta-1a or Intramuscular Interferon Beta-1a

Background: Although socioeconomic disparities that lead to differences in multiple sclerosis (MS) outcomes have been identified, specific...

Read More

Poster-Disease-modifying Therapy

COVID-19 Prevention Behaviors and PCR Testing Among MS Patients Treated with Different Dmts: Survey Data from MS Paths

Background: Emerging data from people with multiple sclerosis (PwMS) suggest that some disease-modifying therapies (DMTs) may impact the...

Read More

Poster-Case Reports / Case Series

Bad Lettuce? Frozen Vegetables? Undercooked Steak? Case Report of Systemic Listeria Monocytogenes Infection in a Patient on Dimethyl Fumarate

Background: The use of disease modifying treatments (DMTs) in multiple sclerosis (MS) has been well studied and has shown to reduce...

Read More